TGAlertsBot

Каналингиз репостлари ва эсловлари ҳақида хабар беради.

TGStat Bot

Telegram'дан чиқмай туриб каналлар статистикасини олиш

SearcheeBot

Telegram-каналлар оламидаги сизнинг йўлбошчингиз.

Telegram Analytics

TGStat хизмати янгиликларидан бохабар бўлиш учун обуна бўл!

Statistika Saralanganlar

Genica NEWS

Kanal geosi va tili: AQSh, Inglizcha

Toifa: Tibbiyot

🌍✨ Dive into a world where science meets the future. Experience groundbreaking gene-editing advancements and astonishing progress in regenerative medicine. Stay steps ahead with unparalleled insights! 🚀🔬
Ads and copyright issues: @genica_adm

Связанные каналы | Похожие каналы

Kanal geosi va tili

AQSh, Inglizcha

Toifa

Tibbiyot

Statistika

Postlar filtri

O‘chirilganlarni yashirish

Repostlarni yashirish

Genica NEWS

22 Dec, 19:42

Pioneering research identifies three subtypes of osteosarcoma for better treatment

Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care.
news-medical.net/news/20241220/Pioneering-research-identifies-three-subtypes-of-osteosarcoma-for-better-treatment.aspx

---
@Genica_NEWS

20 0 0

Genica NEWS

20 Dec, 09:47

New insights into glioblastoma resistance to temozolomide

In spite of intensive research, glioblastoma remains one of the most lethal types of brain cancer. Temozolomide (TMZ) is used as the front-line medicine in its treatment.
news-medical.net/news/20241219/New-insights-into-glioblastoma-resistance-to-temozolomide.aspx

---
@Genica_NEWS

25 0 0

Genica NEWS

19 Dec, 19:41

Nasal fungi differ in people with allergies and asthma

This study identifies key differences in nasal fungi composition in asthma and allergy patients, offering insights into their role in airway disease dynamics.
news-medical.net/news/20241219/Nasal-fungi-differ-in-people-with-allergies-and-asthma.aspx

---
@Genica_NEWS

25 0 0

Genica NEWS

19 Dec, 15:41

Breakthrough in antigen recognition: TRACeR-I enhances immune targeting

Researchers describe TRACeR-I, a protein platform that can be used to engineer immune responses.
news-medical.net/news/20241219/Breakthrough-in-antigen-recognition-TRACeR-I-enhances-immune-targeting.aspx

---
@Genica_NEWS

26 0 0

Genica NEWS

19 Dec, 11:40

Surgeons slow to adopt new biomaterials for bone defects

Two million bone transplants are performed worldwide yearly, including half a million in the United States alone. Yet, a QUT-led study has found surgeons are slow to adopt newly developed biomaterials or tissue-engineered solutions.
news-medical.net/news/20241219/Surgeons-slow-to-adopt-new-biomaterials-for-bone-defects.aspx

---
@Genica_NEWS

23 0 1

Genica NEWS

19 Dec, 03:41

Could microalgae fermentation create the superfoods of the future?

Microalgae fermentation unlocks sustainable and nutritious food production, offering bioactive peptides with antidiabetic properties but faces challenges in consumer acceptance.
news-medical.net/news/20241218/Could-microalgae-fermentation-create-the-superfoods-of-the-future.aspx

---
@Genica_NEWS

22 0 1

Genica NEWS

18 Dec, 19:39

Plymouth researchers lead initiative to advance the study of meningiomas in NF2-SWN

Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN).
news-medical.net/news/20241218/Plymouth-researchers-lead-initiative-to-advance-the-study-of-meningiomas-in-NF2-SWN.aspx

---
@Genica_NEWS

20 0 1

Genica NEWS

18 Dec, 15:41

bit.bio raises $30 million led by M&G Investments

bit.bio, the global leader in cell programming technology, today announced the successful closing of a $30 million financing round led by M&G Investments, a leading international savings and investment company.
news-medical.net/news/20241218/bitbio-raises-2430-million-led-by-MG-Investments.aspx

---
@Genica_NEWS

24 0 0

Genica NEWS

17 Dec, 07:40

Breakthrough microchip technology enables multi-disease detection

In a world grappling with a multitude of health threats -; ranging from fast-spreading viruses to chronic diseases and drug-resistant bacteria -; the need for quick, reliable, and easy-to-use home diagnostic tests has never been greater. Imagine a future where these tests can be done anywhere, by anyone, using a device as small and portable as your smartwatch.
news-medical.net/news/20241216/Breakthrough-microchip-technology-enables-multi-disease-detection.aspx

---
@Genica_NEWS

23 0 0

Genica NEWS

17 Dec, 07:39

WashU Medicine receives $10.8 million grant to advance blood cancer research

Continuing its role as a leader in leukemia research, Washington University School of Medicine in St. Louis has been awarded a five-year, $10.8 million grant to further its exceptional programs in leukemia and other blood cancers.
news-medical.net/news/20241216/WashU-Medicine-receives-24108-million-grant-to-advance-blood-cancer-research.aspx

---
@Genica_NEWS

28 0 0

Genica NEWS

16 Dec, 23:37

Novel drug holds promise for treating Duchenne muscular dystrophy

A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration.
news-medical.net/news/20241216/Novel-drug-holds-promise-for-treating-Duchenne-muscular-dystrophy.aspx

---
@Genica_NEWS

22 0 1

Genica NEWS

16 Dec, 19:45

A new era of targeted therapy with antibody–drug conjugates

TBC
news-medical.net/news/20241216/A-new-era-of-targeted-therapy-with-antibodye28093drug-conjugates.aspx

---
@Genica_NEWS

25 0 1

Genica NEWS

14 Dec, 15:43

Understanding viral composition in marine species from the South China Sea

Announcing a new article publication for Zoonoses journal. This study investigates the viral diversity associated with marine organisms in the South China Sea, to improve understanding of the region's viral ecosystems.
news-medical.net/news/20241214/Understanding-viral-composition-in-marine-species-from-the-South-China-Sea.aspx

---
@Genica_NEWS

35 0 0

Genica NEWS

14 Dec, 07:41

Insilico Medicine gets first clinical milestone payment of $10 million for XL309

Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announced that it has received the first clinical milestone payment of $10 million for XL309 (previously known as ISM3091) from Exelixis.
news-medical.net/news/20241212/Insilico-Medicine-gets-first-clinical-milestone-payment-of-2410-million-for-XL309.aspx

---
@Genica_NEWS

36 0 0

Genica NEWS

13 Dec, 15:41

New protein platform enhances cancer immunotherapy

Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular structure of TRACeR-I, a protein platform for reprogramming immune responses. A better understanding of its structure may help optimize designs for the platform, which can be used to develop cancer treatments by either directly modifying immune cells or by creating proteins that help immune cells locate cancer cells. The findings were published today by the journal Nature Biotechnology.
news-medical.net/news/20241213/New-protein-platform-enhances-cancer-immunotherapy.aspx

---
@Genica_NEWS

38 0 1

Genica NEWS

12 Dec, 11:42

Harnessing exosomes to deliver therapeutic proteins

Researchers at The Ottawa Hospital and the University of Ottawa have discovered an 18-digit code that allows proteins to attach themselves to exosomes - tiny pinched-off pieces of cells that travel around the body and deliver biochemical signals.
news-medical.net/news/20241211/Harnessing-exosomes-to-deliver-therapeutic-proteins.aspx

---
@Genica_NEWS

31 0 0

Genica NEWS

12 Dec, 09:47

Enjoy our content? Advertise on this channel and reach a highly engaged audience! 👉🏻

It's easy with Telega.io. As the leading platform for native ads and integrations on Telegram, it provides user-friendly and efficient tools for quick and automated ad launches.

⚡️ Place your ad here in three simple steps:

1 Sign up

2 Top up the balance in a convenient way

3 Create your advertising post

If your ad aligns with our content, we’ll gladly publish it.

Start your promotion journey now!

27 0 0

Genica NEWS

11 Dec, 19:43

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with endocrine therapy-pretreated, ER-positive, HER2-negative advanced breast cancer-;as monotherapy in patients with ESR1 mutations and as combination therapy with abemaciclib (Verzenio) in all patients, regardless of ESR1 mutation status-;according to results from the phase III EMBER-3 clinical trial presented at the San Antonio Breast Cancer Symposium (SABCS), held December 10-13, 2024.
news-medical.net/news/20241211/Imlunestrant-offers-new-hope-for-ER-positive-HER2-negative-breast-cancer.aspx

---
@Genica_NEWS

34 0 0

Genica NEWS

10 Dec, 08:02

Scientists uncover genetic code driving tumor formation and spread

A group of scientists at VCU Massey Comprehensive Cancer Center has revealed a new genetic code that acts like a cancer ringleader, recruiting and deploying a gang of tumor cells to incite a biological turf war by invading healthy organs and overpowering the normal cells.
news-medical.net/news/20241209/Scientists-uncover-genetic-code-driving-tumor-formation-and-spread.aspx

---
@Genica_NEWS

43 0 0

Genica NEWS

9 Dec, 19:47

Two studies show potential for newborn genetic screening

Two studies published today in the American Journal of Human Genetics show the potential for genomic screening in newborns to address high rates of infant hospitalization and mortality in the United States.
news-medical.net/news/20241209/Two-studies-show-potential-for-newborn-genetic-screening.aspx

---
@Genica_NEWS

39 0 0

20 ta oxirgi post ko‘rsatilgan.

651

obunachilar

Kanal statistikasi

Kanalda mashhur

Study reveals key protein substitutions affect SARS-CoV-2 susceptibility in mammals Announcing a...

Scientists uncover genetic code driving tumor formation and spread A group of scientists at VCU ...

Pregnancy and breastfeeding cause major changes in mothers' intestines When women are pregnant a...

Two studies show potential for newborn genetic screening Two studies published today in the Amer...

UChicago scientists develop a new approach to study snoRNAs Dynamic, reversible modifications of...